288 related articles for article (PubMed ID: 26760772)
1. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
[TBL] [Abstract][Full Text] [Related]
2. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression.
Ishimura A; Minehata K; Terashima M; Kondoh G; Hara T; Suzuki T
Development; 2012 Feb; 139(4):749-59. PubMed ID: 22241836
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
[TBL] [Abstract][Full Text] [Related]
4. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
[TBL] [Abstract][Full Text] [Related]
5. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
[TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
7. JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation.
Huang X; Zhang S; Qi H; Wang Z; Chen HW; Shao J; Shen J
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2286-95. PubMed ID: 26025680
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
9. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
10. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
[TBL] [Abstract][Full Text] [Related]
11. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.
Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ
J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.
Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C
Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737
[TBL] [Abstract][Full Text] [Related]
13. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
14. Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand.
Zhang S; Xia C; Xu C; Liu J; Zhu H; Yang Y; Xu F; Zhao J; Chang Y; Zhao Q
Int J Oncol; 2017 Mar; 50(3):805-814. PubMed ID: 28098878
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
Yao Y; Zhou WY; He RX
Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
[TBL] [Abstract][Full Text] [Related]
16. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
19. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
[TBL] [Abstract][Full Text] [Related]
20. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
